Drug companies fines:
Time Business reports AstraZeneca paid $520 million fine for off-label marketing for antipsychotic
- Seroquel had FDA approval for use in short-term treatment of schizophrenia and acute bipolar
- aggressively marketed the drug as a long-term cure-all for a broad spectrum of psychiatric maladies, including…aggression and agitation in children even though clinical studies have sometimes shown “serious and debilitating side effects
- typically prescribed by psychiatrists but was being marketed to general medical practitioners including staff at nursing homes, veterans, hospitals, prisons, neighbourhood paediatricians
- making patients “guinea pigs in an unsupervised drug test: according to a prosecutor
Pfizer paid 2.3 billion dollars
Johnson & Johnson slapped with $1.2 billion penalty in Arkansas for using fraudulent tactics to sell Risperdal.
Reuters reports that a jury at Pulaski County Circuit Court in Little Rock, Ark., recently found J & J guilty of
illegally marketing Risperdal for unapproved uses, bilking the Arkansas state Medicaid insurance program for millions of dollars, and withholding the truth about the drug’s deadly side effects.
Wed April 11, 2012 Reporting by Ransdell Pierson and Lewi Krauskopf in New York
Arkansas judge fines J & J $1.1 B in Resperdal case
- alleging they misled doctors throughout the state in a letter that downplayed Risperdal’s side effects
- State attorney General Dustin McDaniel said in an emailed statement that the ruling “sends a clear signal that
big drug companies like Johnson & Johnson and Janssen Pharmaceuticals cannot lie to the (U.S. Food and Drug Administration), patients and doctors in order to defraud Arkansas taxpayers of our Medicaid dollars.”
Drug company pays record-setting fines
Pfizer has been fined $2.3 billion dollars
Peter Ostrow Sept 3, 2009
Buffalo, NY (WIVB) – The world’s biggest drug company is paying record-setting fines for illegally promoting drugs for problems they weren’t approved to treat. Using drugs for conditions beyond the ones they were originally approved for is a practice that’s widespread and usually beneficial.
Forsenic evidence emergest that European e.coli superbug was bioengineered to produce human fatalities
Drug Company Fined Over Child Deaths In Experiments
GlaxoSmithKline (GSK), the second largest pharmaceutical company in the world, has been fined over illegal vaccine experiements which killed 14 babies in Argentina between 2007 and 2008
GlaxoSmithKline to pay $750 M find in fraud case
Federal prosecutors in Boston yestserday said British drug giant GSK PLC agreed to pay $750 million to settle civil and criminal charges that it made and sold adulterated drug, including the antidepressandt Paxil, to Medicaid and other goverment payers.
And I am sure we have forgotten the deaths from cyanide-laced Extra-strength Tylenol?
Johnson & Johnson
1982 Chicago Tylenol murders
- September 29, 1982, a “Tylenol scare” began when the first of seven individiuals died in metropolitan Chicago after ingesting Extra Strength Tylenol tha thad been deliberately laced with cyanide
- within a week, the company pulled 31 million bottles of capsules back from retailers, making it one of the first major recalls in American history
- the incident led to reforms in the packaging of the over-the-counter substances and to federal anti-tampering laws
- the case remains unsolved and no suspects have been charged
2010 children’s product recall
- April 30, 2010, McNeil Consumers Healthcare, a subsidiary of Johnson an dhohnson, voluntarily recalled 43 over-the-counter children’s medicines, including Tylenal, Tylenol Plus, Motrin, Zyrtec and Benadryl
- the recall was conducted after a routine inspection at a manufacturing facililty in Fort Washington, Pennsylvania and United States
- affeted products may contain a “higher concentration of active ingredients” or exhibit other manufacturing defects
- products shipped to Canada, Dominican Republic, Guam, Guateala, Jamaica, Puerto Rico, Panama, Trinadad and Tobago, the United Arab Emirates, Kuwait and Fiji were included in the recall
2010 Hip replacement recall
- August 29, 2010, DePuy, a subsidiary of American
giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip
prostheses from the market
- DePuy said the recall was due to unpublished National Joint Registry data showing a 12% revision rate for resurfacing at five years and an ASR XL revision rate of 13%
- all hip prostheses fail in some patients, but it is
expected that the rate will be about 1% a year
- pathologically, the failing prosthesis had several effects
- metal debris from wear of the implant led to a reaction that destroyed the soft tissues surrounding the joint, leaving some patients with long term disability
- ions of cobalt and chromium –the metals from which the implants was made– were also released into the blood and cerebral spinal fluid in some patients
GlaxoSmithKline to appeal Argentine vaccine fines
The world’s second-largest drug maker was fined $93,000 for protocol problems involving the company’s
recruitment of children under for clinical trials in several Argentine provinces.
The investigative judge also fined two investigators nearly $70,000 each because consent forms were signed by
illiterate parents or people who didn’t have custody, according to a source in Aguinsky’s office, who spoke on condition of anonymity because the ruling is being challenged.
GlaxoSmithKline. Where Billions in Fines Don’t Dent the Bottom Line
After our Kleptocracy-controlled Supreme Court made it easy for corporations to shield themselves from class action lawsuits with their April 2011 “AT&T Mobility v Concepcion” decision, those settlements are likely to be much smaller.
So for any companies that might be ethically challenged, the pervasive profit motive may often have them asking this:
“Which is better for our bottom line? To do the right thing, or just pay the fine?”
For the multinational Big Pharma conglomerate GlaxoSmithKline, it would be reasonable to assume that the asking of this question is not an occasional moral crisis but a standard operating procedure. In support of this contention,
consider that only yesterday the Wall Street Journal reported the following:
“In one of the largest settlements of it’s kind, GlaxoSmithKline PLC said it will pay the US government $3 billion to settle several long-running criminal and civil investigations into the company, including allegations that Glaxo
marketed some drugs illegally and defraided the medicaid program.”
If you are looking for products you can trust: